These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3181280)

  • 21. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach.
    Briceland LL; Nightingale CH; Quintiliani R; Cooper BW; Smith KS
    Arch Intern Med; 1988 Sep; 148(9):2019-22. PubMed ID: 3415406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost containment associated with decreased parenteral antibiotic administration frequencies.
    Tanner DJ; Nazarian MQ
    Am J Med; 1984 Oct; 77(4C):104-11. PubMed ID: 6496524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible savings with appropriate antibiotic prophylaxis.
    Hodgson T; Lannigan R; Mills D
    Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial formulary management: a consultant's perspective.
    Holzman MS
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):14S-18S. PubMed ID: 2011568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower antibiotic costs attributable to clinical microbiology rounds.
    Huang RS; Guervil DJ; Hunter RL; Wanger A
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):68-73. PubMed ID: 26025545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
    Rüttimann S; Keck B; Hartmeier C; Maetzel A; Bucher HC
    Clin Infect Dis; 2004 Feb; 38(3):348-56. PubMed ID: 14727204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and cost-effectiveness of antibiotic monitoring at a Veterans Administration hospital.
    O'Hanley P; Rodondi L; Coleman R
    Chemotherapy; 1991; 37 Suppl 3():22-5. PubMed ID: 1909229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling use of antimicrobials in a community teaching hospital.
    Philmon C; Smith T; Williamson S; Goodman E
    Infect Control Hosp Epidemiol; 2006 Mar; 27(3):239-44. PubMed ID: 16532410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modifying empiric antibiotic prescribing: experience with one strategy in a medical residency program.
    MacCosbe PE; Gartenberg G
    Hosp Formul; 1985 Sep; 20(9):986-8, 993-5, 999. PubMed ID: 10274168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of time and practice resources required to provide weekly or monthly erythropoiesis-stimulating protein therapy to chronic kidney disease patients in the physician office setting.
    Bernardo M; Crawford P; Hertel J; Sholer C; Xu X; Goss T; Kewalramani R; Globe D
    J Manag Care Pharm; 2006; 12(9):714-25. PubMed ID: 17249904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic pharmacoeconomics: an attempt to find the real cost of hospital antibiotic prescribing.
    Kerr JR; Barr JG; Smyth ET; O'Hare J; Bell PM; Callender ME
    Ulster Med J; 1993 Apr; 62(1):50-7. PubMed ID: 8516976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmaco-economic aspects of antibiotic therapy in hospitals].
    Delporte JP
    Rev Med Liege; 1998 May; 53(5):279-84. PubMed ID: 9689883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of the district hospital: a case study in Malawi.
    Mills AJ; Kapalamula J; Chisimbi S
    Bull World Health Organ; 1993; 71(3-4):329-39. PubMed ID: 8324852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in antibiotic costs by restricting use of an oral cephalosporin.
    Seligman SJ
    Am J Med; 1981 Dec; 71(6):941-4. PubMed ID: 7315856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multidisciplinary antimicrobial stewardship programme safely decreases the duration of broad-spectrum antibiotic prescription in Singaporean adult renal patients.
    Cai Y; Shek PY; Teo I; Tang SS; Lee W; Liew YX; Chlebicki P; Kwa AL
    Int J Antimicrob Agents; 2016 Jan; 47(1):91-6. PubMed ID: 26706421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a selective restriction policy on antibiotic expenditure and use: an institutional model.
    Suwangool P; Moola-Or P; Waiwatana A; Sitthi-Amorn C; Israsena S; Hanvanich M
    J Med Assoc Thai; 1991 Jul; 74(7):272-5. PubMed ID: 1765742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.